Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02367066
What this trial is testing

A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 30
Testing effectiveness (Phase 2)Study completedNCT00952445
What this trial is testing

A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type II
InteKrin Therapeutics, Inc. 70
Testing effectiveness (Phase 2)Ended earlyNCT05297045
What this trial is testing

Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Regor Pharmaceuticals Inc. 17
Early research (Phase 1)Study completedNCT06333977
What this trial is testing

LC542019 in Healthy Subjects and Subjects With T2DM

Who this might be right for
HealthyDiabetes Mellitus, Type 2
LG Chem 100
Large-scale testing (Phase 3)Study completedNCT01106677
What this trial is testing

The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 1,284
Early research (Phase 1)Study completedNCT01159353
What this trial is testing

Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 37
Large-scale testing (Phase 3)Ended earlyNCT03420781
What this trial is testing

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03

Who this might be right for
GastroparesisDiabetes Mellitus
Allergan 467
Large-scale testing (Phase 3)Study completedNCT00473330
What this trial is testing

Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

Who this might be right for
Diabetes MellitusMacular Edema
Genentech, Inc. 377
Post-approval studies (Phase 4)Study completedNCT01515228
What this trial is testing

Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)

Who this might be right for
Coronary Artery Disease
CHEOL WHAN LEE, MD, PhD. 291
Large-scale testing (Phase 3)Study completedNCT01032629
What this trial is testing

CANVAS - CANagliflozin cardioVascular Assessment Study

Who this might be right for
Diabetes Mellitus, Type 2Cardiovascular DiseasesRisk Factors
Janssen Research & Development, LLC 4,330
Early research (Phase 1)Study completedNCT02147431
What this trial is testing

A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 38
Large-scale testing (Phase 3)Study completedNCT01698775
What this trial is testing

Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 213
Post-approval studies (Phase 4)Study completedNCT05813496
What this trial is testing

Phase IV Trial to Evaluate Efficacy of Alpha-Lipoic Acid in Treating Symptomatic Diabetic Polyneuropathy in Egypt

Who this might be right for
Polyneuropathy, Diabetic
Eva Pharma 430
Testing effectiveness (Phase 2)Study completedNCT02091596
What this trial is testing

Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot UlcerInfection
PluroGen Therapeutics, Inc 42
Testing effectiveness (Phase 2)Study completedNCT02691247
What this trial is testing

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

Who this might be right for
Diabetes Mellitus
Lisata Therapeutics, Inc. 113
Early research (Phase 1)Study completedNCT02562326
What this trial is testing

A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Adocia 51
Large-scale testing (Phase 3)Study completedNCT00351832
What this trial is testing

Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 236
Early research (Phase 1)Study completedNCT01919684
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Ligand Pharmaceuticals 56
Large-scale testing (Phase 3)Active Not RecruitingNCT06777238
What this trial is testing

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 274
Large-scale testing (Phase 3)Study completedNCT02532855
What this trial is testing

Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 614
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation